Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 44301 - 44325 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Fotemustine	Investigational	FOS	2353	upregulated	fotemustine results in increased expression of FOS mRNA	14q24.3	A21557
Fotemustine	Investigational	GADD45A	1647	upregulated	fotemustine results in increased expression of GADD45A mRNA	1p31.3	A22723
Fotemustine	Investigational	JUN	3725	upregulated	fotemustine results in increased expression of JUN mRNA	1p32.1	A21557
Fotemustine	Investigational	POLH	5429	upregulated	fotemustine results in increased expression of POLH mRNA	6p21.1	A22723
Fotemustine	Investigational	TREX1	11277	upregulated	fotemustine results in increased expression of TREX1 mRNA	3p21.31	A21557
Fructose	Approved Investigational	ACACB	32	downregulated	Fructose results in decreased expression of ACACB mRNA	12q24.11	A22724
Fructose	Approved Investigational	APOA4	337	upregulated	Fructose results in increased expression of APOA4 mRNA	11q23.3	A22725
Fructose	Approved Investigational	HNF4A	3172	downregulated	Fructose results in decreased expression of HNF4A mRNA	20q13.12	A22726
Fructose	Approved Investigational	ICAM1	3383	upregulated	Fructose results in increased expression of ICAM1 mRNA	19p13.2	A22727
Fructose	Approved Investigational	MYC	4609	downregulated	Fructose results in decreased expression of MYC mRNA	8q24.21	A22173
Fructose	Approved Investigational	PPARGC1A	10891	downregulated	Fructose results in decreased expression of PPARGC1A mRNA	4p15.2	A22724
Fructose	Approved Investigational	SCD	6319	upregulated	Fructose results in increased expression of SCD mRNA	10q24.31	A22724
Fructose	Approved Investigational	SLC2A4	6517	downregulated	Fructose results in decreased expression of SLC2A4 mRNA	17p13.1	A22724
Fructose	Approved Investigational	SLC2A5	6518	upregulated	Fructose results in increased expression of SLC2A5 mRNA	1p36.23	A21745 A22728
Fulvestrant	Approved Investigational	ABCC3	8714	upregulated	fulvestrant results in increased expression of ABCC3 mRNA	17q21.33	A21102
Fulvestrant	Approved Investigational	ABCC5	10057	downregulated	fulvestrant results in decreased expression of ABCC5 mRNA	3q27.1	A21102
Fulvestrant	Approved Investigational	ABHD2	11057	downregulated	fulvestrant results in decreased expression of ABHD2 mRNA	15q26.1	A21106
Fulvestrant	Approved Investigational	AHNAK	79026	downregulated	fulvestrant results in decreased expression of AHNAK mRNA	11q12.3	A20479
Fulvestrant	Approved Investigational	ALAD	210	upregulated	fulvestrant results in increased expression of ALAD mRNA	9q32	A21106
Fulvestrant	Approved Investigational	APOD	347	upregulated	fulvestrant results in increased expression of APOD mRNA	3q29	A20479
Fulvestrant	Approved Investigational	AR	367	downregulated	fulvestrant results in decreased expression of AR mRNA	Xq12	A21128
Fulvestrant	Approved Investigational	AREG	374	downregulated	fulvestrant results in decreased expression of AREG mRNA	4q13.3	A21116 A20479 A21106
Fulvestrant	Approved Investigational	AREG	374	upregulated	fulvestrant results in increased expression of AREG mRNA	4q13.3	A21102
Fulvestrant	Approved Investigational	ARNT2	9915	upregulated	fulvestrant results in increased expression of ARNT2 mRNA	15q25.1	A20479
Fulvestrant	Approved Investigational	ASNS	440	downregulated	fulvestrant results in decreased expression of ASNS mRNA	7q21.3	A20479

Displaying entries 44301 - 44325 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability